title: Serodiagnosis for tumor viruses.
abstract: The known human tumor viruses include the DNA viruses Epstein-Barr virus (EBV), Kaposi sarcoma herpesvirus (KSHV), Merkel cell polyomavirus (MCPyV), human papillomavirus (HPV), and hepatitis B virus (BV). RNA tumor viruses include human T-cell lymphotrophic virus type 1 (HTLV-1) and hepatitis C virus (HCV). The serological identification of antigens/antibodies in serum is a rapidly progressing field with utility for both scientists and clinicians. Serology is useful for conducting seroepidemiology studies and to inform on the pathogenesis and host immune response to a particular viral agent. Clinically, serology is useful for diagnosing current or past infection and for aiding in clinical management decisions. Serology is useful for screening blood donations for infectious agents and for monitoring the outcome of vaccination against these viruses. Serodiagnosis of human tumor viruses has improved in recent years with increased specificity and sensitivity of the assays, as well as reductions in cost and the ability to assess multiple antibody/antigens in single assays. Serodiagnosis of tumor viruses plays an important role in our understanding of the prevalence and transmission of these viruses and ultimately in the ability to develop treatments/preventions for these globally important diseases.
authors.affiliation: Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD.
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Morrison
authors.affiliation: Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
authors.forename: Nazzarena
authors.initials: N
authors.lastname: Labo
authors.affiliation: Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD.
authors.forename: Wendell J
authors.initials: WJ
authors.lastname: Miley
authors.affiliation: Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD. Electronic address: whitbyd@mail.nih.gov.
authors.forename: Denise
authors.initials: D
authors.lastname: Whitby
mesh_terms: D000914:Antibodies, Viral / Q000097:blood*; D006801:Humans; D009369:Neoplasms / Q000821:virology*; D009858:Oncogenic Viruses; D012698:Serologic Tests / Q000379:methods* / Q000639:trends
chemical_list: D000914:Antibodies, Viral
references.citation: Science. 2008 Feb 22;319(5866):1096-100
references.pmid: 18202256
references.citation: J Clin Virol. 2001 Dec;23(1-2):57-63
references.pmid: 11595584
references.citation: Front Oncol. 2014 Jan 13;3:328
references.pmid: 24455487
references.citation: Prog Clin Biol Res. 1983;105:99-106
references.pmid: 6304775
references.citation: PLoS Pathog. 2014 Mar 27;10(3):e1004046
references.pmid: 24675986
references.citation: Int J Cancer. 2014 Feb 15;134(4):844-8
references.pmid: 23922031
references.citation: Proc Assoc Am Physicians. 1999 Nov-Dec;111(6):581-7
references.pmid: 10591087
references.citation: Hepatol Int. 2007 Jun;1(2):311-5
references.pmid: 19669355
references.citation: J Med Virol. 2003 Sep;71(1):115-23
references.pmid: 12858417
references.citation: J Clin Microbiol. 1995 May;33(5):1357-9
references.pmid: 7542272
references.citation: Cancer. 2001 Oct 1;92(7):1872-80
references.pmid: 11745260
references.citation: Ann Dermatol. 2013 May;25(2):203-7
references.pmid: 23717012
references.citation: J Infect Dis. 2004 Oct 15;190(8):1382-6
references.pmid: 15378429
references.citation: Lancet. 2001 Mar 24;357(9260):934-5
references.pmid: 11289355
references.citation: J Clin Microbiol. 1996 Dec;34(12):3240-1
references.pmid: 8940484
references.citation: Clin Vaccine Immunol. 2008 Sep;15(9):1410-3
references.pmid: 18632919
references.citation: Virology. 2004 Apr 10;321(2):205-16
references.pmid: 15051381
references.citation: Oncogene. 2003 Aug 11;22(33):5181-91
references.pmid: 12910255
references.citation: J Natl Cancer Inst. 1997 May 7;89(9):630-8
references.pmid: 9150187
references.citation: Prog Clin Biol Res. 1983;105:169-76
references.pmid: 6304754
references.citation: Clin Liver Dis. 2010 Feb;14(1):169-76; x
references.pmid: 20123448
references.citation: J Natl Cancer Inst. 1958 Jun;20(6):1223-43
references.pmid: 13549981
references.citation: Proc Natl Acad Sci U S A. 1987 Jan;84(2):570-4
references.pmid: 3025881
references.citation: J Hepatol. 2006;44(1 Suppl):S6-9
references.pmid: 16352363
references.citation: Clin Gastroenterol Hepatol. 2007 Dec;5(12):1462-8
references.pmid: 18054753
references.citation: MMWR Morb Mortal Wkly Rep. 2013 May 10;62(18):362-5
references.pmid: 23657112
references.citation: Expert Rev Gastroenterol Hepatol. 2008 Aug;2(4):553-62
references.pmid: 19072403
references.citation: Lancet Infect Dis. 2007 Jul;7(7):453-9
references.pmid: 17597569
references.citation: Blood. 1995 Aug 15;86(4):1276-80
references.pmid: 7632932
references.citation: J Hepatol. 2000 Dec;33(6):998-1002
references.pmid: 11131465
references.citation: N Engl J Med. 2007 May 10;356(19):1944-56
references.pmid: 17494927
references.citation: Infect Agent Cancer. 2007 Jul 09;2:13
references.pmid: 17620119
references.citation: Nature. 2011 Jun 08;474(7350):S2-4
references.pmid: 21666731
references.citation: N Engl J Med. 2000 May 4;342(18):1309-15
references.pmid: 10793163
references.citation: Blood. 1989 Nov 15;74(7):2585-91
references.pmid: 2804381
references.citation: J Infect Dis. 2009 Mar 15;199(6):837-46
references.pmid: 19434930
references.citation: Cent Eur J Public Health. 2008 Sep;16(3):106-10
references.pmid: 18935772
references.citation: Nat Rev Cancer. 2007 Apr;7(4):270-80
references.pmid: 17384582
references.citation: Lancet. 2004 Nov 13-19;364(9447):1757-65
references.pmid: 15541448
references.citation: Front Microbiol. 2012 Jan 20;3:6
references.pmid: 22319516
references.citation: N Engl J Med. 1989 Mar 16;320(11):689-95
references.pmid: 2537928
references.citation: J Gen Virol. 2010 Jul;91(Pt 7):1840-8
references.pmid: 20181747
references.citation: J Hepatol. 2006 Oct;45(4):529-38
references.pmid: 16879891
references.citation: Infect Dis Obstet Gynecol. 2006;2006 Suppl:40470
references.pmid: 16967912
references.citation: N Engl J Med. 1998 Feb 12;338(7):423-8
references.pmid: 9459645
references.citation: Transfusion. 2002 Jun;42(6):780-91
references.pmid: 12147033
references.citation: Biochim Biophys Acta. 2008 Mar;1782(3):127-50
references.pmid: 18201576
references.citation: J Immunol. 1978 Oct;121(4):1239-44
references.pmid: 81224
references.citation: Clin Dermatol. 1997 Mar-Apr;15(2):249-59
references.pmid: 9167909
references.citation: Int J Cancer. 2010 Dec 15;127(12):2893-917
references.pmid: 21351269
references.citation: Lancet. 1991 Aug 24;338(8765):512-3
references.pmid: 1678470
references.citation: Lancet. 1971 Jun 19;1(7712):1257-60
references.pmid: 4104715
references.citation: Pract Neurol. 2009 Feb;9(1):16-26
references.pmid: 19151234
references.citation: Am J Clin Pathol. 2002 Jan;117(1):156-61
references.pmid: 11789721
references.citation: PLoS One. 2013 Apr 25;8(4):e61182
references.pmid: 23634207
references.citation: J Clin Lab Anal. 1999;13(2):65-8
references.pmid: 10102134
references.citation: Lancet Oncol. 2012 Jun;13(6):607-15
references.pmid: 22575588
references.citation: Int J Cancer. 2001 Feb 15;91(4):588-91
references.pmid: 11251987
references.citation: J Natl Cancer Inst. 2004 Sep 15;96(18):1368-74
references.pmid: 15367569
references.citation: J Med Virol. 2001 Jun;64(2):157-66
references.pmid: 11360248
references.citation: N Engl J Med. 1999 Jul 1;341(1):22-6
references.pmid: 10387938
references.citation: Hepatology. 2001 Jul;34(1):194-203
references.pmid: 11431751
references.citation: AIDS. 2004 Sep 3;18(13):1819-26
references.pmid: 15316343
references.citation: J Infect Dis. 2010 Jun 15;201(12):1919-22
references.pmid: 20443737
references.citation: Nat Med. 1996 Aug;2(8):925-8
references.pmid: 8705864
references.citation: Int J Cancer. 2007 Mar 1;120(5):1129-35
references.pmid: 17154170
references.citation: J Virol. 1997 Aug;71(8):5915-21
references.pmid: 9223481
references.citation: Intervirology. 1995;38(1-2):24-34
references.pmid: 8666521
references.citation: Lancet Infect Dis. 2002 Jul;2(7):395-403
references.pmid: 12127351
references.citation: J Clin Oncol. 2009 Jan 20;27(3):453-9
references.pmid: 19064971
references.citation: Vaccine. 2006 Jul 7;24(27-28):5571-83
references.pmid: 16753240
references.citation: J Gastroenterol Hepatol. 2002 Feb;17(2):165-70
references.pmid: 11966946
references.citation: J Viral Hepat. 2001 Mar;8(2):87-95
references.pmid: 11264728
references.citation: Proc Soc Exp Biol Med. 1960 Nov;105:420-7
references.pmid: 13774265
references.citation: J Clin Microbiol. 2000 Jan;38(1):105-9
references.pmid: 10618072
references.citation: Am J Epidemiol. 2008 Aug 1;168(3):311-20
references.pmid: 18515794
references.citation: Proc Soc Exp Biol Med. 1953 Jun;83(2):414-21
references.pmid: 13064287
references.citation: Hepatology. 2008 Feb;47(2):428-34
references.pmid: 18220290
references.citation: Gastroenterology. 1991 Jan;100(1):182-8
references.pmid: 1983820
references.citation: Ann Intern Med. 1993 Mar 15;118(6):448-54
references.pmid: 8382459
references.citation: J Immunol Methods. 2010 Apr 30;356(1-2):39-46
references.pmid: 20211626
references.citation: Am J Epidemiol. 1976 Jan;103(1):1-12
references.pmid: 174424
references.citation: N Engl J Med. 2000 Aug 17;343(7):481-92
references.pmid: 10944566
references.citation: Infect Agent Cancer. 2011 Sep 30;6(1):15
references.pmid: 21962023
references.citation: Int J Cancer. 2006 Jun 15;118(12):3030-44
references.pmid: 16404738
references.citation: J Hepatol. 2002 Feb;36(2):303-4
references.pmid: 11830346
references.citation: Clin Diagn Lab Immunol. 2000 May;7(3):451-6
references.pmid: 10799460
references.citation: Hepatology. 2013 Apr;57(4):1333-42
references.pmid: 23172780
references.citation: Gastroenterology. 2000 Mar;118(3):554-9
references.pmid: 10702206
references.citation: Methods. 2006 Apr;38(4):294-303
references.pmid: 16481197
references.citation: Science. 2002 May 10;296(5570):1012-5
references.pmid: 12004103
references.citation: Clin Infect Dis. 2000 Sep;31(3):739-51
references.pmid: 11017824
references.citation: Clin Diagn Lab Immunol. 2003 Mar;10(2):278-85
references.pmid: 12626455
references.citation: N Engl J Med. 1999 Jun 17;340(24):1863-71
references.pmid: 10369849
references.citation: Am J Epidemiol. 2008 Jul 15;168(2):123-37
references.pmid: 18483125
references.citation: Nature. 1978 Aug 24;274(5673):756-61
references.pmid: 210392
references.citation: Cancer Res. 2010 Nov 1;70(21):8388-97
references.pmid: 20959478
references.citation: J Clin Microbiol. 2000 Jun;38(6):2174-80
references.pmid: 10834972
references.citation: IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt B):1-441
references.pmid: 23189750
references.citation: Lancet. 1971 Jun 19;1(7712):1253-7
references.pmid: 4104714
references.citation: J Med Virol. 2010 Sep;82(9):1606-11
references.pmid: 20648617
references.citation: Cancer Res. 2013 Jun 1;73(11):3441-50
references.pmid: 23729642
references.citation: J Clin Microbiol. 1997 Jul;35(7):1734-9
references.pmid: 9196183
references.citation: Med Microbiol Immunol. 2011 Feb;200(1):7-11
references.pmid: 20461405
references.citation: Int J STD AIDS. 2004 Jan;15(1):7-16
references.pmid: 14769164
references.citation: Dis Colon Rectum. 2005 Jan;48(1):86-91
references.pmid: 15690663
references.citation: Clin Vaccine Immunol. 2006 Apr;13(4):511-9
references.pmid: 16603621
references.citation: Am J Med. 2004 Jun 15;116(12):829-34
references.pmid: 15178498
references.citation: Int J Hematol. 2003 Nov;78(4):280-96
references.pmid: 14686485